Ozempic linked to rare cases of vision loss in Harvard study [Fortune]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Fortune
loss, according to an analysis by doctors at Massachusetts Eye and Ear, a Harvard-affiliated hospital. Patients who took the drugs for weight loss were more than seven times more likely to be diagnosed with a stroke-like eye condition, known as NAION, than those taking other classes of drugs for obesity , according to the study of patient records. Those taking the drugs for diabetes were more than four times more likely to develop the rare ailment than people on other types of treatments, according to the results published Wednesday in the journal JAMA Ophthalmology The relatively small study examined the records of Massachusetts Eye and Ear patients. The low number of cases of the eye condition in people who took the drugs — 37 between both groups — limited the study's statistical power, according to the paper. The findings don't prove the medications caused the eye complication and must be replicated in larger studies involving more hospitals, the Harvard researchers and other e
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal [Seeking Alpha]Seeking Alpha
- GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with Lilly [Yahoo! Finance]Yahoo! Finance
- GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with LillyBusiness Wire
- 3 No-Brainer Stocks to Buy in July [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 7/8/24 - Form 4
- 7/3/24 - Form 4
- 7/2/24 - Form 4
- LLY's page on the SEC website